Real Time Screeners Intraday Screeners now on Real Time Data (Updated every 5 mins)
Stock Listing : A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z 

Stock Analysis of Wockhardt , Birds-Eye-view On Returns/Technicals/Funda/F&O

About Strength Screener

Charts Of Wockhardt Ltd.

1D   1W   2W   1M   3M   1Y   2Y   5Y   
Interactive Charts

Price / Volume Action

EOD Share Price177.85
Previous Share Price172.65
Price Change 5.20
Change % 3.01%
Volume433.36 K
Five Day Avg Vol411.31 K
Last Business Date01-Apr-20

Price Gain/Loss

DurationAbsolute ChgChg %
One Week 11.50 6.91
Two Weeks -18.75 -9.54
One Month -129.50 -42.13
Three Months -57.15 -24.32
Six Months -77.80 -30.43
One Year -277.15 -60.91

Highs / Lows

One Week186.95165.0
Two Weeks194.7146.7
One Month329.3146.7
Three Months411.65146.7
Six Months411.65146.7
One Year460.0146.7

Key Moving Average

5 Days 173.29173.869
15 Days 183.573195.039
20 Days 211.315208.906
50 Days 288.186252.36
100 Days 271.448271.215
200 Days 287.422304.126
Detailed MA Analysis of WOCKPHARMA ...

Key Technical Indicators

MACD -36.36
RSI 38.10
RSI (Smooth) 32.34
ADX 48.62
Chaikin Money Flow -0.093
Williams %R -61.16
PSAR 149.07
Detailed Tech Analysis WOCKPHARMA ...

Financial Data Highlights

Market Cap1910.15
Book Value/ Share229.135
Enterprise Value264.86
Revenue TTM3513.57
Gross Profit TTM2262.09
Revenue /Share TTM317.30
Consensus Target450.00
Key Financial Highlights WOCKPHARMA ...

Financial Ratios of WOCKPHARMA

Div Yield0
Trailing PE0
Forward PE0
Key Financial Ratios of WOCKPHARMA ...

Key Profit & Loss Data

Net Inc -194.53 68.02 %
Ops Income-31.09 84.83 %
Revenue4158.38 5.96 %
Ops Expense4189.47 1.45 %
PBT-300.32 53.16 %
Gross Profit2262.09 9.27 %
Div Paid-0.0200 80.00 %

Price Range (PR) /Volatility

PeriodAvg PR Range %
LBD PR9.955.59
Week PR18.0010.12
Month PR9.955.59
5 Day Period10.566.23
10 Day Period13.998.66
5 Week Period53.7631.13
3 Months Period147.1280.84
Price Range /Volatility WOCKPHARMA ...

Highlights & Chart Patterns of Wockhardt Ltd.

Stock has jumped by more than 10% in last two weeks from its lowest level of 146.7 dt 24-Mar-20
Stock has jumped by more than 15% in last One Month from its lowest level of 146.7 dt 24-Mar-20.
Stock has fallen by more than 15% in last One Month from its highest level of 329.3 dt 05-Mar-20.
Stock has fallen by more than 25% in last three Month from its highest level of 411.65 dt 11-Feb-20.
Stock has fallen by more than 50% in last three Month from its highest level of 411.65 dt 11-Feb-20.
Stock has fallen to less than half in last One Year from its Highest level of 460.0 dt 15-Apr-19.
Spinning top Candlestick pattern was formed by Wockhardt Ltd. on 31/03/2020
More Chart Patterns Wockhardt Ltd. ...
You can now customize Equity with technical , SMA , Fin Data, chart patterns in one Page. Click here to view guide

Share Price History of Wockhardt Ltd.

Date Open High Low Close Volume
01-Apr-20 173.95 183.00 173.05 177.85 433 K
31-Mar-20 173.40 176.85 168.90 172.65 213 K
30-Mar-20 170.00 172.40 165.00 169.05 661 K
27-Mar-20 178.00 186.95 170.00 172.25 361 K
26-Mar-20 169.95 179.00 166.00 174.65 387 K
25-Mar-20 151.00 171.00 151.00 166.35 369 K
24-Mar-20 162.00 168.00 146.70 156.20 313 K
23-Mar-20 165.00 171.00 161.25 161.25 161 K
20-Mar-20 186.00 192.00 172.35 179.15 688 K
19-Mar-20 190.00 194.70 177.00 181.60 738 K
About Wockhardt Limited
Wockhardt Limited, a pharmaceutical and biotechnology company, manufactures and markets active pharmaceutical ingredients (APIs), formulations, bio-similars, and vaccines in India, the United States, Europe, and internationally. It provides pharmaceutical products in the therapeutic areas of anti-infective, cardiology, dermatology, diabetology, neurology, pain management, respiratory, and other areas. The company offers generic products that comprise injectables, including cephalosporins and non-cephalosporins; molecules; and value-added generics. Its biopharmaceutical products include Glaritus, an insulin analog; Wosulin, a r-DNA insulin; Wepox, a recombinant erythropoietin is used in the treatment of anemia caused by cancer and chronic renal failure; and Biovac-B, a hepatitis B vaccine. The company also provides contract manufacturing services for sterile injectables, lyophilisation, and other dosage forms; and research services. It develops various molecules primarily in the area of anti-infectives, which include WCK 771 that is in Phase II human clinical trials for the treatment of staphylococcal infections; and WCK 2349, WCK 4873, and WCK 4086 lead molecules, which are under pre-clinical trials. The company was incorporated in 1999 and is headquartered in Mumbai, India. Wockhardt Limited is a subsidiary of Themisto Trustee Company Private Limited.
About Strength

Strength is based on Deep Analysis, Back Testing and Historical Trend Analysis using Machine Learning. Overall Technical Strength is based on 50+ indicators including Technicals, moving Avg, chart patterns, candlestick and proprietary algorithms.Technical Strength is currently calculated around around 5 to 6 PM. This is an automated process and in NO WAY should be considered as a tip as its based on past data. We strongly recommend to use these signals for information only and seek advise from a certified professional for any trading decision.If you like it then please share. The more the visitors the more the innovations. Feedback

We are working on fundamental strength also. Please share your views to help shape up the requirement.

( Intraday Analysis is on Real Time Data (Updated every 5 Mins). All Other analysis is based on End of Trade day's Value. Expected time of update is between 5 to 5.30 PM exchange time Zone)

All Rights Reserved By Mintnovate Market Research Pvt Ltd.